businesspress24.com - Biotech: Pressemitteilungen - Kategorie - Seite 232
 

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Medivation and Astellas Announce Positive Survival Data From Interim Analysis of Phase 3 AFFIRM Trial of MDV3100 in Men With Advanced Prostate Cancer

SAN FRANCISCO, CA and TOKYO: Study Will Be Stopped Early and MDV3100 Offered to All Participants; Medivation to Hold Conference Call at 8:30AM Eastern Time Today ...

The Medicines Company Announces Schedule of Events at Upcoming Transcatheter Cardiovascular Therapeutics (TCT) Conference

PARSIPPANY, NJ: First Angiomax(R) (Bivalirudin) Data in Structural Heart Disease Procedures; Cangrelor Bridge Featured as Late Breaking Trial ...

Hepregen Corporation and Partners Present Findings at Key Research Meeting

MEDFORD, MA: HepatoPac(TM) Liver Model Is Touted for Its Value to Predict Clinical Parameters of Commercially Available Drugs ...

Marina Biotech Demonstrates That Its Novel UsiRNA Oligonucleotide Abrogates Cytotoxicity Resulting From microRNA-Like Off-Target Activity

BOTHELL, WA: Data Generated Under an Early Collaborative Effort Demonstrated Abrogation of Cytotoxicity Associated With microRNA-Like Off-Targeting by Substituting a Single Unlocked Nucleobase Analog (UNA) Moiety ...

ISTA Pharmaceuticals Reports Third Quarter 2011 Financial Results

IRVINE, CA: ISTA Posts Profitable Quarter With Adjusted Cash Net Income of $4.1 Million Net Revenues in the Third Quarter of 2011 Increased 12% Compared to the Second Quarter of 2011 Positive Phase 3 Results Anno ...


Page 232 von 247:  « ..  231 232 233  234  235  236  237  238  239  240  .. » 247





 

Who is online

All members: 10 568
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 86


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.